Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 3502386, 7 pages
https://doi.org/10.1155/2017/3502386
Research Article

Heparanase Overexpresses in Keratoconic Cornea and Tears Depending on the Pathologic Grade

1Instituto Universitario Fernández Vega, Universidad de Oviedo & Fundación de Investigación Oftalmológica, Oviedo, Spain
2Department of Functional Biology, University of Oviedo, 33006 Oviedo, Spain
3Department of Morphology and Cell Biology, University of Oviedo, 33006 Oviedo, Spain
4Department of Organic and Inorganic Chemistry, University of Oviedo, 33006 Oviedo, Spain
5Department of Microbiology, Hospital Universitario Central de Asturias, Oviedo, Spain

Correspondence should be addressed to Luis M. Quirós; se.ivoinu@siulsoriuq

Received 7 July 2017; Revised 23 October 2017; Accepted 16 November 2017; Published 12 December 2017

Academic Editor: Stamatios E. Theocharis

Copyright © 2017 Beatriz García et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Romero-Jiménez, J. Santodomingo-Rubido, and J. S. Wolffsohn, “Keratoconus: a review,” Contact Lens & Anterior Eye, vol. 33, no. 4, pp. 157–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Zhang, X. Mao, T. Schwend, S. Littlechild, and G. W. Conrad, “Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases,” Investigative Ophthalmology & Visual Science, vol. 54, no. 2, pp. 1014–1025, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. L. Khaled, I. Helwa, M. Drewry, M. Seremwe, A. Estes, and Y. Liu, “Molecular and histopathological changes associated with keratoconus,” Biomed Research International, vol. 2017, Article ID 7803029, 16 pages, 2017. View at Publisher · View at Google Scholar
  4. J. Vazirani and S. Basu, “Keratoconus: current perspectives,” Clinical Ophthalmology, vol. 7, pp. 2019–2030, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Jun, L. Cope, C. Speck et al., “Subnormal cytokine profile in the tear fluid of keratoconus patients,” PLoS One, vol. 6, no. 1, article e16437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Sarrazin, W. C. Lamanna, and J. D. Esko, “Heparan sulfate proteoglycans,” Cold Spring Harbor Perspectives in Biology, vol. 3, no. 7, article a004952, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Mobli, M. Nilsson, and A. Almond, “The structural plasticity of heparan sulfate NA-domains and hence their role in mediating multivalent interactions is confirmed by high-accuracy 15N-NMR relaxation studies,” Glycoconjugate Journal, vol. 25, no. 5, pp. 401–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. U. Lindahl and L. Kjellén, “Pathophysiology of heparan sulphate: many diseases, few drugs,” Journal of Internal Medicine, vol. 273, no. 6, pp. 555–571, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. L. Funderburgh, M. L. Funderburgh, M. M. Rodrigues, J. H. Krachmer, and G. W. Conrad, “Altered antigenicity of keratan sulfate proteoglycan in selected corneal diseases,” Investigative Ophthalmology & Visual Science, vol. 31, no. 3, pp. 419–428, 1990. View at Google Scholar
  10. J. L. Funderburgh, N. D. Hevelone, M. R. Roth et al., “Decorin and biglycan of normal and pathologic human corneas,” Investigative Ophthalmology & Visual Science, vol. 39, no. 10, pp. 1957–1964, 1998. View at Google Scholar
  11. S. Akhtar, A. J. Bron, A. J. Hayes, K. M. Meek, and B. Caterson, “Role of keratan sulphate (sulphated poly-N-acetyllactosamine repeats) in keratoconic cornea, histochemical, and ultrastructural analysis,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 249, no. 3, pp. 413–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Chaerkady, H. Shao, S. G. Scott, A. Pandey, A. S. Jun, and S. Chakravarti, “The keratoconus corneal proteome: loss of epithelial integrity and stromal degeneration,” Journal of Proteomics, vol. 87, pp. 122–131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. B. García, O. García-Suárez, J. Merayo-Lloves et al., “Differential expression of proteoglycans by corneal stromal cells in keratoconus,” Investigative Ophthalmology & Visual Science, vol. 57, no. 6, pp. 2618–2628, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Meirovitz, R. Goldberg, A. Binder, A. M. Rubinstein, E. Hermano, and M. Elkin, “Heparanase in inflammation and inflammation-associated cancer,” FEBS Journal, vol. 280, no. 10, pp. 2307–2319, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. R. S. Berk, Z. Dong, S. Alousi, M. A. Kosir, Y. Wang, and I. Vlodavsky, “Murine ocular heparanase expression before and during infection with Pseudomonas aeruginosa,” Investigative Ophthalmology & Visual Science, vol. 45, no. 4, pp. 1182–1187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Arvatz, I. Shafat, F. Levy-Adam, N. Ilan, and I. Vlodavsky, “The heparanase system and tumor metastasis: is heparanase the seed and soil?” Cancer and Metastasis Reviews, vol. 30, no. 2, pp. 253–268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Levy-Adam, S. Feld, V. Cohen-Kaplan et al., “Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity,” Journal of Biological Chemistry, vol. 285, no. 36, pp. 28010–28019, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Fernández-Vega, O. García, A. Crespo et al., “Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer,” BMC cancer, vol. 13, no. 1, p. 24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. B. García, O. García-Suárez, I. Fernández-Vega, A. Vallina, A. Astudillo, and L. M. Quirós, “Heparanase and heparanase 2 display differently deregulation in neuroendocrine tumors, depending on their differentiation grade,” Histology and Histopathology, vol. 31, no. 1, pp. 73–81, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Freeman and C. R. Parish, “A rapid quantitative assay for the detection of mammalian heparanase activity,” Biochemical Journal, vol. 325, no. 1, pp. 229–237, 1997. View at Publisher · View at Google Scholar
  21. M. D. Hulett, C. Freeman, B. J. Hamdorf, R. T. Baker, M. J. Harris, and C. R. Parish, “Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis,” Nature Medicine, vol. 5, no. 7, pp. 803–809, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Vlodavsky, M. Blich, J. P. Li, R. D. Sanderson, and N. Ilan, “Involvement of heparanase in atherosclerosis and other vessel wall pathologies,” Matrix Biology, vol. 32, no. 5, pp. 241–251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Abu El-Asrar, K. Alam, M. I. Nawaz et al., “Upregulated expression of heparanase in the vitreous of patients with proliferative diabetic retinopathy originates from activated endothelial cells and leukocytes,” Investigative Ophthalmology & Visual Science, vol. 56, no. 13, pp. 8239–8247, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Galvis, T. Sherwin, A. Tello, J. Merayo, R. Barrera, and A. Acera, “Keratoconus: an inflammatory disorder?” Eye, vol. 29, no. 7, pp. 843–859, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. V. J. Coulson-Thomas, S. H. Chang, L. K. Yeh et al., “Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing,” Investigative Ophthalmology & Visual Science, vol. 56, no. 5, pp. 3004–3014, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. R. L. McKown, N. Wang, R. W. Raab et al., “Lacritin and other new proteins of the lacrimal functional unit,” Experimental Eye Research, vol. 88, no. 5, pp. 848–858, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Zhang, D. S. Ryan, K. S. Bower, N. Ilan, I. Vlodavsky, and G. W. Laurie, “Focus on molecules: heparanase,” Experimental Eye Research, vol. 91, no. 4, pp. 476-477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Ilan, M. Elkin, and I. Vlodavsky, “Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis,” The International Journal of Biochemistry & Cell Biology, vol. 38, no. 12, pp. 2018–2039, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. A. Balasubramanian, V. C. Wasinger, D. C. Pye, and M. D. Willcox, “Preliminary identification of differentially expressed tear proteins in keratoconus,” Molecular Vision, vol. 19, pp. 2124–2134, 2013. View at Google Scholar
  30. P. S. Tsai, J. E. Evans, K. M. Green et al., “Proteomic analysis of human meibomian gland secretions,” British Journal of Ophthalmology, vol. 90, no. 3, pp. 372–377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Okrojek, F. H. Grus, N. Matheis, and G. J. Kahaly, “Proteomics in autoimmune thyroid eye disease,” Hormone and Metabolic Research, vol. 41, no. 6, pp. 465–470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Zhou, R. W. Beuerman, L. P. Ang et al., “Elevation of human α-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium,” Investigative Ophthalmology & Visual Science, vol. 50, no. 5, pp. 2077–2086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Määttä, O. Kari, T. Tervahartiala et al., “Tear fluid levels of MMP-8 are elevated in ocular rosacea–treatment effect of oral doxycycline,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 244, no. 8, pp. 957–962, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. B. S. Koo, D. Y. Lee, H. S. Ha, J. C. Kim, and C. W. Kim, “Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis,” Journal of Proteome Research, vol. 4, no. 3, pp. 719–724, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Herber, F. H. Grus, P. Sabuncuo, and A. J. Augustin, “Changes in the tear protein patterns of diabetic patients using two-dimensional electrophoresis,” Advances in Experimental Medicine and Biology, vol. 506, Part A, pp. 623–626, 2001. View at Publisher · View at Google Scholar
  36. F. H. Grus, P. Sabuncuo, S. Herber, and A. J. Augustin, “Analysis of tear protein patterns for the diagnosis of dry eye,” in Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3, pp. 1213–1216, Springer, Boston, MA, USA, 2002. View at Google Scholar
  37. A. Acera, E. Vecino, I. Rodríguez-Agirretxe et al., “Changes in tear protein profile in keratoconus disease,” Eye, vol. 25, no. 9, pp. 1225–1233, 2011. View at Publisher · View at Google Scholar · View at Scopus